Hagen B, van Dijk J, Zhang Q, Overkleeft H, van der Marel G, Codee J
Org Lett. 2017; 19(10):2514-2517.
PMID: 28485610
PMC: 5442609.
DOI: 10.1021/acs.orglett.7b00747.
ORiordan K, Lee J
Clin Microbiol Rev. 2004; 17(1):218-34.
PMID: 14726462
PMC: 321462.
DOI: 10.1128/CMR.17.1.218-234.2004.
Luong T, Ouyang S, Bush K, Lee C
J Bacteriol. 2002; 184(13):3623-9.
PMID: 12057957
PMC: 135137.
DOI: 10.1128/JB.184.13.3623-3629.2002.
Thomas C, Li Y, Kodama T, Suzuki H, Silverstein S, El Khoury J
J Exp Med. 2000; 191(1):147-56.
PMID: 10620613
PMC: 2195800.
DOI: 10.1084/jem.191.1.147.
Ouyang S, Sau S, Lee C
J Bacteriol. 1999; 181(8):2492-500.
PMID: 10198014
PMC: 93676.
DOI: 10.1128/JB.181.8.2492-2500.1999.
Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus.
Sau S, Sun J, Lee C
J Bacteriol. 1997; 179(5):1614-21.
PMID: 9045821
PMC: 178874.
DOI: 10.1128/jb.179.5.1614-1621.1997.
A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
Fattom A, Sarwar J, Ortiz A, Naso R
Infect Immun. 1996; 64(5):1659-65.
PMID: 8613375
PMC: 173976.
DOI: 10.1128/iai.64.5.1659-1665.1996.
Cloning of type 8 capsule genes and analysis of gene clusters for the production of different capsular polysaccharides in Staphylococcus aureus.
Sau S, Lee C
J Bacteriol. 1996; 178(7):2118-26.
PMID: 8606192
PMC: 177913.
DOI: 10.1128/jb.178.7.2118-2126.1996.
Complement resistance in microbes.
Moffitt M, Frank M
Springer Semin Immunopathol. 1994; 15(4):327-44.
PMID: 8153871
DOI: 10.1007/BF01837364.
Genetic analysis of type 5 capsular polysaccharide expression by Staphylococcus aureus.
Lee J, Xu S, Albus A, Livolsi P
J Bacteriol. 1994; 176(16):4883-9.
PMID: 8051001
PMC: 196323.
DOI: 10.1128/jb.176.16.4883-4889.1994.
Presence of a capsule in Erysipelothrix rhusiopathiae and its relationship to virulence for mice.
Shimoji Y, Yokomizo Y, Sekizaki T, Mori Y, Kubo M
Infect Immun. 1994; 62(7):2806-10.
PMID: 8005671
PMC: 302885.
DOI: 10.1128/iai.62.7.2806-2810.1994.
Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus.
Lin W, Cunneen T, Lee C
J Bacteriol. 1994; 176(22):7005-16.
PMID: 7961465
PMC: 197074.
DOI: 10.1128/jb.176.22.7005-7016.1994.
Chemotaxigenesis by encapsulated Staphylococcus aureus M.
Schmeling D, Peterson P, Barr I, Kim Y, Quie P
Infect Immun. 1980; 27(2):700-3.
PMID: 7380548
PMC: 550823.
DOI: 10.1128/iai.27.2.700-703.1980.
Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus.
King B, Wilkinson B
Infect Immun. 1981; 33(3):666-72.
PMID: 7287175
PMC: 350759.
DOI: 10.1128/iai.33.3.666-672.1981.
Encapsulated, coagulase-negative strain of Staphylococcus simulans.
Anderson J, Wilson C
Infect Immun. 1981; 33(1):304-8.
PMID: 7263067
PMC: 350690.
DOI: 10.1128/iai.33.1.304-308.1981.
Morphological examination of the glycocalyces of Staphylococcus aureus strains Wiley and Smith.
Caputy G, Costerton J
Infect Immun. 1982; 36(2):759-67.
PMID: 7085077
PMC: 351295.
DOI: 10.1128/iai.36.2.759-767.1982.
Surface polysaccharide from Staphylococcus aureus M that contains taurine, D-aminogalacturonic acid, and D-fucosamine.
Liau D, MELLY M, Hash J
J Bacteriol. 1974; 119(3):913-22.
PMID: 4854538
PMC: 245699.
DOI: 10.1128/jb.119.3.913-922.1974.
Catalase and superoxide dismutase activities in virulent and nonvirulent Staphylococcus aureus isolates.
Kanafani H, Martin S
J Clin Microbiol. 1985; 21(4):607-10.
PMID: 3988902
PMC: 271729.
DOI: 10.1128/jcm.21.4.607-610.1985.
Possible common biological and immunological properties for detecting encapsulated strains of Staphylococcus epidermidis.
Yamada T, Ichiman Y, Yoshida K
J Clin Microbiol. 1988; 26(10):2167-72.
PMID: 3053765
PMC: 266838.
DOI: 10.1128/jcm.26.10.2167-2172.1988.
Characterization of clinical strains of Staphylococcus aureus associated with pneumonia.
Sanford B, Thomas V, Ramsay M, Jones T
J Clin Microbiol. 1986; 24(1):131-6.
PMID: 3013927
PMC: 268847.
DOI: 10.1128/jcm.24.1.131-136.1986.